Ph. 858 586 0500    Toll Free 800 854 7453

Receptors and Channels

RYK Peptide

$50.00
SKU: 350485
RYK is a potential growth factor receptor protein tyrosine kinase.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cell Growth and Death
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Tyrosine-protein kinase RYK
Composition 
C88H146N24O29S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200123 is selected from a sequence within the N-term region of human RYK. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
2036.3 g/mol
Unit 
0.1 mg

HGFR Peptide

$50.00
SKU: 350475
HGFR (MET), a tyrosine protein kinase, is the receptor for the hepatocyte growth factor and scater factor. Activation of HGFR after rearrangement with the TPR gene produces an oncogenic protein c-MET. Defects in HGFR/MET are a cause of hepatocellular carcinoma and renal carcinoma.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cancers
Cell Communication
Development and Behavior
Infectious Diseases
Signaling Molecules and Interaction
Format 
Each vial contains 0.1 ml peptide in deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Hepatocyte growth factor receptor; HGF receptor; Scatter factor receptor; SF receptor; HGF/SF receptor; Met proto-oncogene tyrosine kinase; c-Met
Composition 
C83H139N23O27S3
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200113 is selected from a sequence within the N-term region of human HGFR. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1987.3 g/mol
Unit 
0.1 mg

DDR1 Peptide

$50.00
SKU: 350474
DDR1 is involved in cell-cell interactions and recognition.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cell Communication
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Epithelial discoidin domain-containing receptor 1; Epithelial discoidin domain receptor 1; Tyrosine kinase DDR; Discoidin receptor tyrosine kinase; Tyrosine-protein kinase CAK; Cell adhesion kinase; TRK E; Protein-tyrosine kinase RTK 6; CD167a antigen; HGK2; DDR1; EDDR1; NEP; NTRK4; PTK3A; RTK6; TRKE
Composition 
C84H137N25O30S2
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200112 is selected from a sequence within the N-term region of human DDR1. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
2041.2 g/mol
Unit 
0.1 mg

KIT Peptide

$50.00
SKU: 350473
KIT is the receptor for stem cell factor (mast cell growth factor). KIT has a tyrosine protein kinase activity. Defects in KIT are a cause of piebaldism (lack of melanocytes), gastrointestinal stromal tumors and testicular tumors.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cancers
Endocrine System
Immune System
Signaling Molecules and Interaction
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Mast/stem cell growth factor receptor; SCFR; Proto-oncogene tyrosine-protein kinase Kit; c-kit; CD117 antigen; KIT
Composition 
C80H128N24O29S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200111 is selected from a sequence within the C-term region of human KIT. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1922.1 g/mol
Unit 
0.1 mg

INSR Peptide

$50.00
SKU: 350472
INSR binds insulin and has a tyrosine protein kinase activity. The short isoform has a higher affinity for insulin. The receptor mediates the metabolic functions of insulin. The receptor binding to insulin stimulates association of the receptor with downstream mediators including IRS1 and phosphatidylinositol 3'-kinase (PI3K). Defects in INSR are the cause of insulin resistance.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cell Communication
Endocrine System
Metabolic Disorders
Neurodegenerative Disorders
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Insulin receptor; CD220 antigen; IR; INSR
Composition 
C87H138N24O25S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200110 is selected from a sequence within the N-term region of human INSR. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1952.2 g/mol
Unit 
0.1 mg

IGF1R Peptide

$50.00
SKU: 350471
IGF1R binds insulin-like growth factor 1 (IGF1) with high affinity and IGF2 with low affinity. The receptor has a tyrosine protein kinase activity necessary for the activation of the IGF1-stimulated downstream signaling cascade.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cancers
Cell Communication
Nervous and Sensory Systems
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Insulin-like growth factor I receptor; CD221 antigen; IGF-I receptor; IGF1R
Composition 
C72H125N25O24S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200109 is selected from a sequence within the C-term region of human IGF1R. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1757 g/mol
Unit 
0.1 mg

FGFR4 Peptide

$50.00
SKU: 350469
FGFR4 is a receptor for acidic fibroblast growth factor but does not bind to basic fibroblast growth factor.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cell Motility
Signal Transduction
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Fibroblast growth factor receptor 4; FGFR-4; CD334 antigen; FGFR4; JTK2; TKF
Composition 
C77H117N29O23S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200107 is selected from a sequence within the N-term region of human FGFR4. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1849 g/mol
Unit 
0.1 mg

FGFR2 Peptide

$50.00
SKU: 350468
FGFR2 is a receptor for acidic and basic fibroblast growth factors. Defects in FGFR2 are the cause of numerous craniofacial abnormalities such as Crouzon, Jackson-Weiss, and Apert syndromes.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cancers
Cell Motility
Signal Transduction
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Fibroblast growth factor receptor 2; FGFR-2; Keratinocyte growth factor receptor 2; CD332 antigen; FGFR2; BEK; KGFR; KSAM
Composition 
C84H131N19O32S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200106 is selected from a sequence within the N-term region of human FGFR2. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1951.1 g/mol
Unit 
0.1 mg

EphB2 Peptide

$50.00
SKU: 350467
EphB2 is a receptor for members of the ephrin-B family and acts as a tumor suppressor. Defects in EphB2 are involved in the development of prostate cancer metastasis to the brain.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cancers
Development and Behavior
Signaling Molecules and Interaction
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Ephrin type-B receptor 2 precursor; Tyrosine-protein kinase receptor EPH-3; DRT; Receptor protein-tyrosine kinase HEK5; ERK; Renal carcinoma antigen NY-REN-47; Tyrosine-protein kinase TYRO5; EPHB2; EPHT3; EPTH3
Composition 
C83H116N20O28S2
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200105 is selected from a sequence within the N-term region of human EphB2. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1906 g/mol
Unit 
0.1 mg

EphA2 Peptide

$50.00
SKU: 350466
EphA2 is a receptor for members of the ephrin-A family. EphA2 binds to ephrin-A1, A3, A4 and A5.
List price: $0.00
Storage 
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Price: $50.00
Pathway and Disease 
Cancers
Signaling Molecules and Interaction
Format 
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
Alternate Names 
Ephrin type-A receptor 2 precursor; Tyrosine-protein kinase receptor ECK; Epithelial cell kinase; EPHA2
Composition 
C85H143N27O21S1C85H143N27O21S1C85H143N27O21S1C85H143N27O21S1C85H143N27O21S1C85H143N27O21S1C85H143N27O21S1
Sequence 
The synthetic peptide used to raise the antibody Cat. No. 200104 is selected from a sequence within the C-term region of human EphA2. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Purity 
Purity > 80% by HPLC
Solubility 
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Release Date 
Monday, December 17, 2012
MW 
1911.3 g/mol
Unit 
0.1 mg

Pages

Subscribe to RSS - Receptors and Channels